Testicular Yolk Sac Tumor Overview

Save information for later
Sign Up

Learn About Testicular Yolk Sac Tumor

What is the definition of Testicular Yolk Sac Tumor?
Testicular yolk sac tumor is a subtype of testicular cancer that most commonly occurs in the testicles of young and middle-age men. While the exact cause is not well understood, some risk factors have been determined, such as undescended testicle, abnormal testicle development, smoking, exposure to some chemicals, family history of testicular cancer, HIV infection, and Down syndrome.
What are the symptoms of Testicular Yolk Sac Tumor?
Testicular yolk sac tumor may have no symptoms or appear as a painless mass in the testes. If symptoms occur, they may include discomfort or pain, or a sense of heaviness in the scrotum, lower back of abdominal pain, an enlarged testicle, or an overgrowth of male breast tissue. The cancer may spread to other parts of the body.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Testicular Yolk Sac Tumor?
Treatment for testicular yolk sac cancer depends on how far the cancer has spread and includes surgery (removal of the testicle), radiation therapy, and chemotherapy. Testicular yolk sac cancer is highly treatable and has a high rate of success. Testicular cancer can be detected early by performing a monthly testicular self-examination.
Who are the top Testicular Yolk Sac Tumor Local Doctors?
Pedro T. Ramirez
Distinguished in Testicular Yolk Sac Tumor
Dr. Pedro T. Ramirez
Gynecologic Oncology | Oncology
Distinguished in Testicular Yolk Sac Tumor
Dr. Pedro T. Ramirez
Gynecologic Oncology | Oncology

Tmh Physician Associates PLLC

6550 Fannin St, Suite 901, 
Houston, TX 
713-441-1026
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Pedro Ramirez is a Gynecologic Oncologist and an Oncologist in Houston, Texas. Dr. Ramirez is rated as a Distinguished provider by MediFind in the treatment of Testicular Yolk Sac Tumor. His top areas of expertise are Cervical Cancer, Ovarian Cancer, Endometrial Cancer, Hysterectomy, and Endoscopy. Dr. Ramirez is currently accepting new patients.

Elite in Testicular Yolk Sac Tumor
Dr. Lawrence H. Einhorn
Hematology Oncology | Oncology | Hematology
Elite in Testicular Yolk Sac Tumor
Dr. Lawrence H. Einhorn
Hematology Oncology | Oncology | Hematology

Iu Health Medical Group LLC

1701 N Senate Blvd, 
Indianapolis, IN 
888-484-3258
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Lawrence Einhorn is a Hematologist Oncology specialist and an Oncologist in Indianapolis, Indiana. Dr. Einhorn is rated as an Elite provider by MediFind in the treatment of Testicular Yolk Sac Tumor. His top areas of expertise are Testicular Cancer, Teratoma of the Mediastinum, Testicular Yolk Sac Tumor, Orchiectomy, and Bone Marrow Transplant. Dr. Einhorn is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Testicular Yolk Sac Tumor
Costantino Ricci
Elite in Testicular Yolk Sac Tumor
Costantino Ricci
Bologna, IT 

Costantino Ricci practices in Bologna, Italy. Mr. Ricci is rated as an Elite expert by MediFind in the treatment of Testicular Yolk Sac Tumor. His top areas of expertise are Testicular Yolk Sac Tumor, Giant Congenital Nevus, Testicular Cancer, and Sertoli-Leydig Cell Tumor.

View All Doctors
What are the latest Testicular Yolk Sac Tumor Clinical Trials?
A Phase 2 Trial of Chemotherapy Followed by Response-Based Whole Ventricular &Amp; Spinal Canal Irradiation (WVSCI) for Patients With Localized Non-Germinomatous Central Nervous System Germ Cell Tumor
A Phase 2 Trial of Chemotherapy Followed by Response-Based Whole Ventricular &Amp; Spinal Canal Irradiation (WVSCI) for Patients With Localized Non-Germinomatous Central Nervous System Germ Cell Tumor
Who is this study for: Patients with localized non-germinomatous central nervous system germ cell tumor
Enrollment Status: Recruiting
Publish Date: September 22, 2025
Intervention Type: Drug, Procedure, Biological, Radiation, Other
Study Drugs: Carboplatin, Etoposide, Filgrastim, Ifosfamide, Mesna, Pegfilgrastim, Thiotepa
Study Phase: Phase 2

Summary: This phase II trial studies the best approach to combine chemotherapy and radiation therapy (RT) based on the patient's response to induction chemotherapy in patients with non-germinomatous germ cell tumors (NGGCT) that have not spread to other parts of the brain or body (localized). This study has 2 goals: 1) optimizing radiation for patients who respond well to induction chemotherapy to diminish...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BGB-B2033, Alone or in Combination With Tislelizumab, in Participants With Selected Advanced or Metastatic Solid Tumors
A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BGB-B2033, Alone or in Combination With Tislelizumab, in Participants With Selected Advanced or Metastatic Solid Tumors
Enrollment Status: Recruiting
Publish Date: September 22, 2025
Intervention Type: Drug
Study Phase: Phase 1

Summary: This study is a first-in-human (FIH) Phase 1 study of BGB-B2033 to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary antitumor activity of the BGB-B2033 in participants with advanced or metastatic hepatocellular carcinoma (HCC), alpha-fetoprotein (AFP)-producing gastric cancer (GC), extragonadal yolk sac tumors, non-dysgerminomas, or glypican-3 (GPC3)-positi...

View All Clinical Trials